Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Calcium Supplementation on ALX1-11 Efficacy in Postmenopausal Osteoporosis
NCT00172172Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2004
- Primary completion
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 3
01
Overview
A Phase 3 trial of parathyroid hormone 1-84 in osteoporosis, sponsored by Takeda. Started Jan 2004; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00172172.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172172.